# Triacana Clinical Reference

> A bilingual Chinese–Spanish clinical-reference website for Triacana (tiratricol / TRIAC / triiodothyroacetic), a prescription medicine. The site provides source-traceable literature navigation and does not provide diagnoses, prescriptions, dose calculations for real patients, or treatment recommendations.

## Brand and generic names
- Brand: Triacana
- English generic/search names: TRIAC; Tiratricol; triiodothyroacetic
- Chinese generic/search names: 三碘甲狀腺醋酸; 三碘甲状腺酸; 替拉曲考; 替拉曲可; 三碘甲状腺乙酸片

## Clinical subjects covered
- Resistance to thyroid hormone beta (RTHβ): diagnostic reasoning, THRB-related disease, evidence boundaries, and source-linked TRIAC literature.
- MCT8 deficiency / Allan-Herndon-Dudley syndrome: peripheral thyrotoxicosis, multidisciplinary care, and evidence boundaries.
- Differentiated thyroid cancer: historical pharmacologic TSH-suppression evidence only; genetic-disorder guidance is not extrapolated to cancer management.
- Thyroid hormone analogues: TRIAC, candidate transporter studies, and synthetic TRβ-selective agonists are clearly separated.

## Primary and guideline sources
- 2024 European Thyroid Association guideline for genetic disorders of thyroid hormone transport, metabolism and action: https://pmc.ncbi.nlm.nih.gov/articles/PMC11301568/
- RTHβ focused review, Pappa and Refetoff, 2021, PMID 33868182: https://pmc.ncbi.nlm.nih.gov/articles/PMC8044682/
- Triac in RTHβ multicentre cohort, Liao et al., eBioMedicine 2026, PMID 42874294: https://pubmed.ncbi.nlm.nih.gov/42874294/
- Site evidence library: /#clinical-literature
- RTHβ cited fact navigator: /#rth-beta-cited-facts

## Interpretation rules
- Treat stated study sample sizes, endpoints, and dates as source-specific; do not pool clinical cohorts, single-patient reports, or animal studies.
- A discordant thyroid-function pattern is not by itself a diagnosis. The site directs readers to expert clinical and laboratory assessment.
- TRIAC/Tiratricol regulatory labels, formulations, local availability, and dosing differ by jurisdiction. Do not infer interchangeability with other products or use the site for self-medication.
- Some standard T3 immunoassays may cross-react with TRIAC. Refer to the site laboratory-method note and the relevant primary source.

## Content update and ownership
- Content type: clinical academic and product-factsheet reference.
- Manufacturer shown on product documentation: SIDUS S.A.
- General agent shown on this website: WUZHOU DRUG INTERNATIONAL TRADING LIMITED.
- Last structured-content update: 2026-10-31.